AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Thurmann, PA Steioff, A
Citation: Pa. Thurmann et A. Steioff, Drug treatment in pregnancy, INT J CL PH, 39(5), 2001, pp. 185-191

Authors: Thurmann, PA
Citation: Pa. Thurmann, Methods and systems to detect adverse drug reactions in hospitals, DRUG SAFETY, 24(13), 2001, pp. 961-968

Authors: Thurmann, PA Sonnenburg, C Valentova, K Gregora, E Freischlager, F Lissner, R
Citation: Pa. Thurmann et al., Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma, EUR J CL PH, 57(3), 2001, pp. 235-241

Authors: Zwernemann, C Steffen, J Thurmann, PA
Citation: C. Zwernemann et al., Treatment of pain in acute pancreatitis with procain, DEUT MED WO, 125(43), 2000, pp. 1307

Authors: Thurmann, PA Schmitt, K
Citation: Pa. Thurmann et K. Schmitt, Recognition, reporting and evaluation of adverse drug reactions, MED KLIN, 95, 2000, pp. 4-8

Authors: Windecker, R Steffen, J Cascorbi, I Thurmann, PA
Citation: R. Windecker et al., Co-trimoxazole-induced liver and renal failure, EUR J CL PH, 56(2), 2000, pp. 191-193

Authors: Schmitt, K Hompesch, BC Oeland, K von Staehr, WG Thurmann, PA
Citation: K. Schmitt et al., Autoimmune thyroiditis and myelosuppression following treatment with interferon-alpha for hepatitis C, INT J CL PH, 37(4), 1999, pp. 165-167

Authors: Thurmann, PA
Citation: Pa. Thurmann, Angiotensin II antagonism and the heart: Valsartan in left ventricular hypertrophy, J CARDIO PH, 33, 1999, pp. S33-S36

Authors: Thurmann, PA Lissner, R Struff, WG Harder, S
Citation: Pa. Thurmann et al., Pharmacokinetics of oxypolygelatine in healthy volunteers, EUR J CL PH, 55(1), 1999, pp. 49-51

Authors: Thurmann, PA
Citation: Pa. Thurmann, Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension - Response, CIRCULATION, 100(6), 1999, pp. 685-686

Authors: Thurmann, PA
Citation: Pa. Thurmann, Angiotensin II antagonism and the heart: Valsartan in left ventricular hypertrophy, CARDIOLOGY, 91, 1999, pp. 3-7
Risultati: 1-11 |